97 related articles for article (PubMed ID: 23142558)
1. The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.
Rossi F; Bellini G; Luongo L; Mancusi S; Torella M; Tortora C; Manzo I; Guida F; Nobili B; de Novellis V; Maione S
Pharmacol Res; 2013 Feb; 68(1):7-15. PubMed ID: 23142558
[TBL] [Abstract][Full Text] [Related]
2. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.
Rossi F; Bellini G; Luongo L; Torella M; Mancusi S; De Petrocellis L; Petrosino S; Siniscalco D; Orlando P; Scafuro M; Colacurci N; Perrotta S; Nobili B; Di Marzo V; Maione S;
Bone; 2011 May; 48(5):997-1007. PubMed ID: 21237298
[TBL] [Abstract][Full Text] [Related]
3. Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Rossi F; Perrotta S; Bellini G; Luongo L; Tortora C; Siniscalco D; Francese M; Torella M; Nobili B; Di Marzo V; Maione S
Haematologica; 2014 Dec; 99(12):1876-84. PubMed ID: 25216685
[TBL] [Abstract][Full Text] [Related]
4. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Chen F; Ouyang Y; Ye T; Ni B; Chen A
J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
[TBL] [Abstract][Full Text] [Related]
7. PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity.
Bellini G; Torella M; Manzo I; Tortora C; Luongo L; Punzo F; Colacurci N; Nobili B; Maione S; Rossi F
Pharmacol Res; 2017 Jan; 115():267-274. PubMed ID: 27919827
[TBL] [Abstract][Full Text] [Related]
8. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
Idris AI; van 't Hof RJ; Greig IR; Ridge SA; Baker D; Ross RA; Ralston SH
Nat Med; 2005 Jul; 11(7):774-9. PubMed ID: 15908955
[TBL] [Abstract][Full Text] [Related]
10. Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
[TBL] [Abstract][Full Text] [Related]
11. The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.
Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
[TBL] [Abstract][Full Text] [Related]
12. Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis.
Zhang D; Zhang J; Fong C; Yao X; Yang M
Biochimie; 2012 Dec; 94(12):2514-22. PubMed ID: 22796380
[TBL] [Abstract][Full Text] [Related]
13. The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen.
Pascoe D; Oursler MJ
J Bone Miner Res; 2001 Jun; 16(6):1028-36. PubMed ID: 11393779
[TBL] [Abstract][Full Text] [Related]
14. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
Karieb S; Fox SW
Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
[TBL] [Abstract][Full Text] [Related]
15. The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma.
Bellini G; Di Pinto D; Tortora C; Manzo I; Punzo F; Casale F; Rossi F
Curr Cancer Drug Targets; 2017; 17(7):650-656. PubMed ID: 27993113
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Rassi CM; Lieberherr M; Chaumaz G; Pointillart A; Cournot G
J Bone Miner Res; 2002 Apr; 17(4):630-8. PubMed ID: 11918220
[TBL] [Abstract][Full Text] [Related]
17. Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
Tortora C; Di Paola A; Creoli M; Argenziano M; Martinelli M; Miele E; Rossi F; Strisciuglio C
Inflamm Bowel Dis; 2022 Aug; 28(8):1244-1253. PubMed ID: 35472140
[TBL] [Abstract][Full Text] [Related]
18. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen on the activity and growth of human osteoclasts in vitro.
Chen FP; Wang KC; Huang JD
Taiwan J Obstet Gynecol; 2009 Dec; 48(4):350-5. PubMed ID: 20045755
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630.
Geng DC; Xu YZ; Yang HL; Zhu XS; Zhu GM; Wang XB
J Biomed Mater Res A; 2010 Oct; 95(1):321-6. PubMed ID: 20623669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
